Improved Survival and Cardiovascular Outcomes with Renin-Angiotensin Inhibitor Use After Transcatheter Aortic Valve Replacement

Authors

Aaqib H. Malik, New York Medical CollegeFollow
Srikanth Yandrapalli
Suchith Shetty
Ajay J. Kirtane
Wilbert S. Aronow, New York Medical CollegeFollow

DOI

10.1016/j.carrev.2020.01.001

Journal Title

Cardiovascular Revascularization Medicine

First Page

694

Last Page

695

Document Type

Review Article

Publication Date

5-2020

Department

Medicine

Keywords

Antihypertensive Agents, Aortic Valve, Blood Pressure, Heart Valve Diseases, Humans, Hypertension, Renin-Angiotensin System, Risk Assessment, Risk Factors, Transcatheter Aortic Valve Replacement, Treatment Outcome

Disciplines

Medicine and Health Sciences

Recommended Citation

Malik, A. H., Yandrapalli, S., Shetty, S., Kirtane, A. J., & Aronow, W. S. (2020). Improved Survival and Cardiovascular Outcomes with Renin-Angiotensin Inhibitor Use After Transcatheter Aortic Valve Replacement. Cardiovascular Revascularization Medicine, 21 (5), 694-695. https://doi.org/10.1016/j.carrev.2020.01.001